Suppr超能文献

不同老年女性对人乳头瘤病毒检测与常规宫颈癌筛查的偏好

Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women.

作者信息

Huang Alison J, Pérez-Stable Eliseo J, Kim Sue E, Wong Sabrina T, Kaplan Celia P, Walsh Judith M E, Iwaoka-Scott A Yuri, Sawaya George F

机构信息

Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.

出版信息

J Gen Intern Med. 2008 Sep;23(9):1324-9. doi: 10.1007/s11606-008-0633-x. Epub 2008 May 28.

Abstract

BACKGROUND

Human papillomavirus (HPV) testing is increasingly being used to determine the optimal cervical cancer screening interval in older women. Little is known about women's attitudes toward HPV testing or how these attitudes may influence medical discussions about cervical cancer screening.

METHODS

Preferences for HPV and concomitant Papanicolaou (Pap) testing were assessed through in-person interviews with diverse women aged 50 to 80 years recruited from community and university-based practices.

RESULTS

Eight hundred and sixty-five women (257 White, 87 African American, 149 Latina, and 372 Asian) were interviewed. Approximately 60% of participants wanted to be tested for HPV and another 15% would undergo testing if recommended by their physician. Among those wanting HPV testing, 94% would want more frequent than annual Pap tests if they had a positive HPV test and a normal Pap test. Two thirds of those under age 65 would be willing to switch to triennial Pap testing, and half of those aged 65 and older would be willing to discontinue Pap testing, if they had a negative HPV test and normal Pap test. Preferences for testing varied by ethnicity, age, place of birth, and cancer history.

CONCLUSIONS

The majority of older women were willing to use HPV testing to make decisions about frequency and duration of cervical cancer screening, but up to one third would want at least annual, ongoing screening regardless of HPV test results. Efforts should be made to ensure that HPV testing is used to reinforce appropriate utilization of screening tests.

摘要

背景

人乳头瘤病毒(HPV)检测越来越多地用于确定老年女性宫颈癌筛查的最佳间隔时间。对于女性对HPV检测的态度,以及这些态度如何影响关于宫颈癌筛查的医学讨论,我们知之甚少。

方法

通过对从社区和大学医疗机构招募的50至80岁不同女性进行面对面访谈,评估她们对HPV检测和同时进行巴氏(Pap)检测的偏好。

结果

共访谈了865名女性(257名白人、87名非裔美国人、149名拉丁裔和372名亚裔)。约60%的参与者希望进行HPV检测,另有15%的人表示如果医生建议就会接受检测。在希望进行HPV检测的人中,如果HPV检测呈阳性且巴氏检测正常,94%的人希望比每年进行一次巴氏检测的频率更高。如果HPV检测呈阴性且巴氏检测正常,65岁以下的人中三分之二愿意改为每三年进行一次巴氏检测,65岁及以上的人中一半愿意停止巴氏检测。检测偏好因种族、年龄、出生地和癌症病史而异。

结论

大多数老年女性愿意使用HPV检测来决定宫颈癌筛查的频率和持续时间,但高达三分之一的人无论HPV检测结果如何,都希望至少每年进行一次持续筛查。应努力确保HPV检测用于加强筛查检测的合理利用。

相似文献

1
Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women.
J Gen Intern Med. 2008 Sep;23(9):1324-9. doi: 10.1007/s11606-008-0633-x. Epub 2008 May 28.
2
Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
J Clin Virol. 2009 Nov;46 Suppl 3:S5-10. doi: 10.1016/S1386-6532(09)70294-X.
5
Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Arch Pathol Lab Med. 2012 Dec;136(12):1533-40. doi: 10.5858/arpa.2011-0609-OA. Epub 2012 Aug 20.
7
Recent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testing.
Prev Med. 2020 Jan;130:105928. doi: 10.1016/j.ypmed.2019.105928. Epub 2019 Nov 19.
8
The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.
Cancer Prev Res (Phila). 2021 Jan;14(1):105-112. doi: 10.1158/1940-6207.CAPR-20-0280. Epub 2020 Sep 11.
10
Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
J Obstet Gynaecol. 2020 Feb;40(2):240-246. doi: 10.1080/01443615.2019.1621813. Epub 2019 Jul 25.

引用本文的文献

2
Acceptable and Preferred Cervical Cancer Screening Intervals Among U.S. Women.
Am J Prev Med. 2015 Dec;49(6):e99-107. doi: 10.1016/j.amepre.2015.04.025. Epub 2015 Jul 2.
3
Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.
Obstet Gynecol. 2015 Feb;125(2):317-329. doi: 10.1097/AOG.0000000000000638.
4
Women's intentions to receive cervical cancer screening with primary human papillomavirus testing.
Int J Cancer. 2013 Dec 15;133(12):2934-43. doi: 10.1002/ijc.28324. Epub 2013 Jul 16.
5
Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists.
Am J Obstet Gynecol. 2013 Feb;208(2):109.e1-7. doi: 10.1016/j.ajog.2012.11.015. Epub 2012 Nov 22.
6
Colorectal cancer screening: what do women from diverse ethnic groups want?
J Gen Intern Med. 2013 Feb;28(2):239-46. doi: 10.1007/s11606-012-2210-6. Epub 2012 Sep 12.
8
Using visual displays to communicate risk of cancer to women from diverse race/ethnic backgrounds.
Patient Educ Couns. 2012 Jun;87(3):327-35. doi: 10.1016/j.pec.2011.11.014. Epub 2012 Jan 12.
9
Trends of human papillomavirus testing in cervical cancer screening at a large academic cytology laboratory.
Obstet Gynecol. 2011 Aug;118(2 Pt 1):289-295. doi: 10.1097/AOG.0b013e3182253c33.
10
How does public policy impact cervical screening and vaccination strategies?
Gynecol Oncol. 2010 Nov;119(2):175-80. doi: 10.1016/j.ygyno.2010.08.021.

本文引用的文献

1
Association between cancer risk perception and screening behavior among diverse women.
Arch Intern Med. 2008 Apr 14;168(7):728-34. doi: 10.1001/archinte.168.7.728.
2
Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
N Engl J Med. 2007 Oct 18;357(16):1589-97. doi: 10.1056/NEJMoa073204.
3
Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.
N Engl J Med. 2007 Oct 18;357(16):1579-88. doi: 10.1056/NEJMoa071430.
4
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests.
Am J Obstet Gynecol. 2007 Oct;197(4):346-55. doi: 10.1016/j.ajog.2007.07.047.
5
Prevalence of HPV infection among females in the United States.
JAMA. 2007 Feb 28;297(8):813-9. doi: 10.1001/jama.297.8.813.
9
A content analysis of news coverage of the HPV vaccine by U.S. newspapers, January 2002-June 2005.
J Womens Health (Larchmt). 2006 Sep;15(7):803-9. doi: 10.1089/jwh.2006.15.803.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验